Back

Select your region

Corporate

Europe:

Flag Albania Albania Flag Bosnia and Herzegovina Bosnia and Herzegovina Flag Bulgaria Bulgaria Flag Croatia Croatia Flag Cyprus Cyprus Flag Montenegro Montenegro Flag Czech Republic Czech Republic Flag Denmark Denmark Flag Estonia Estonia Flag Spain Spain Flag Kosovo Kosovo Flag Lithuania Lithuania Flag Latvia Latvia Flag Luxembourg Luxembourg Flag Macedonia Macedonia Flag Germany Germany Flag Poland Poland Flag Portugal Portugal Flag Romania Romania Flag Serbia Serbia Flag Slovakia Slovakia Flag Slovenia Slovenia Flag Switzerland Switzerland Flag Sweden Sweden Flag Turkey Turkey Flag Hungary Hungary Flag United Kingdom United Kingdom Flag Italy Italy

Asia:

Flag UAE UAE Flag Hong Kong Hong Kong Flag Kuwait Kuwait Flag Lebanon Lebanon

Africa:

Flag South Africa South Africa

Arrange a consultation about stem cells

Learn more

Get in touch with us today!

Would you like to find out more about our services? Fill out the form below and we will contact you as soon as possible to provide you with all the necessary information and answer your questions.

    We would like to point out that the personal data provided in the form will be processed by FamiCord Suisse, based in Switzerland (BusinessPark Zug Sumpfstrasse 26, 6302 Zug), for the purpose of contacting you by telephone in connection with the provision of service information.

    Image

    List of
    transplantations

    List of uses for stem cells approved by the FamiCord Group’s laboratories:

    Image
    List of uses for stem cells approved by the FamiCord Group’s laboratories:
    Nr. Source Source type Diagnosis Medical sector Year of application Therapy Country Age of the recipient
    801 Bone Marrow Allogeneic Fanconi Anemia Hematology 2025 Standard Therapy Poland 11
    802 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 9
    803 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 3
    804 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy France 9
    805 Bone Marrow Allogeneic Fanconi Anemia  Hematology 2025 Standard Therapy Poland 8
    806 Bone Marrow Allogeneic Immune Deficiency Hematology 2025 Standard Therapy United Kingdom 10
    807 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Germany 12
    808 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy USA 20
    809 Bone Marrow Allogeneic Hodgkin Lymphoma Hematology 2025 Standard Therapy Turkey 17
    810 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 13
    811 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Canada 22
    812 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 15
    813 Bone Marrow Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Italy 8
    814 Bone Marrow Allogeneic Inherited Immune System Disorder Hematology 2025 Standard Therapy France 3
    815 Bone Marrow Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 2
    816 Bone Marrow Allogeneic Bone Marrow Failure Hematology 2025 Standard Therapy Netherlands 23
    817 Bone Marrow Allogeneic Chronic Granulomatous Disease Hematology 2025 Standard Therapy Italy 6
    818 Bone Marrow Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 5
    819 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 58
    820 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 34
    821 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 61
    822 Apheresis Allogeneic Myelodysplastic Syndrome/Myeloproliferative neoplasm Hematology 2025 Standard Therapy NETHERLANDS 62
    823 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Austria 68
    824 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 70
    825 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 66
    826 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 77
    827 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Ukraine 12
    828 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 58
    829 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 67
    830 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 4
    831 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 73
    832 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 56
    833 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Italy 50
    834 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Poland 39
    835 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Lithuania 43
    836 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy Poland 66
    837 Apheresis Allogeneic Multiple Myeloma Hematology 2025 Standard Therapy USA 61
    838 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Austria 55
    839 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 69
    840 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Denmark 67
    841 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy United Kingdom 75
    842 Apheresis Allogeneic T – cell Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 24
    843 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Belgium 68
    844 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Ukraine 42
    845 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy USA 50
    846 Apheresis Allogeneic Prolymphocytic Leukemia Hematology 2025 Standard Therapy USA 62
    847 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy United Kingdom 62
    848 Apheresis Allogeneic Chronic Myelomonocytic Leukemia Hematology 2025 Standard Therapy USA 69
    849 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 85
    850 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 54
    851 Apheresis Allogeneic Non-Hodgkin Lymphoma Hematology 2025 Standard Therapy USA 39
    852 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 45
    853 Apheresis Autologous Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 59
    854 Apheresis Allogeneic Multiple myeloma Hematology 2025 Standard Therapy Germany 68
    855 Apheresis Allogeneic Multiple myeloma Hematology 2025 Standard Therapy Germany 68
    856 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 73
    857 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 66
    858 Apheresis Autologous Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 69
    859 Apheresis Autologous Hodgkin lymphoma Hematology 2025 Standard Therapy Germany 38
    860 Apheresis Allogeneic Tcell acute leukemia Hematology 2025 Standard Therapy Romania 31
    861 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Italy 37
    862 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Sweden 69
    863 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 55
    864 Apheresis Allogeneic Fanconi's Anemia Hematology 2025 Standard Therapy Russia 14
    865 Apheresis Allogeneic Peripheral T-cell Lymphoma not otherwise specified Hematology 2025 Standard Therapy Germany 54
    866 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy France 63
    867 Apheresis Allogeneic Myeloid Sarcoma Hematology 2025 Standard Therapy Poland 48
    868 Apheresis Allogeneic Other Myelofibrosis/Myelosclerosis Hematology 2025 Standard Therapy USA 72
    869 Apheresis Allogeneic Severe Aplastic Anemia Hematology 2025 Standard Therapy Germany 11
    870 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 37
    871 Apheresis Allogeneic Myelofibrosis Hematology 2025 Standard Therapy Australia 59
    872 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 35
    873 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Poland 51
    874 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 59
    875 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 70
    876 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy USA 70
    877 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 66
    878 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 63
    879 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 66
    880 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Italy 61
    881 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy USA 71
    882 Apheresis Allogeneic Chronic Lymphocytic Leukemia Hematology 2025 Standard Therapy Czechia 45
    883 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Brazil 61
    884 Apheresis Allogeneic Acute Lymphoblastic Leukemia Hematology 2025 Standard Therapy Hungary 35
    885 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy NETHERLANDS 48
    886 Apheresis Allogeneic Mantle Cell Lymphoma Hematology 2025 Standard Therapy Ireland 62
    887 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Poland 62
    888 Apheresis Allogeneic Acute Myeloid Leukemia, Myelodysplasia-Related Hematology 2025 Standard Therapy Russia 53
    889 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 56
    890 Apheresis Allogeneic Myelofibrosis Myeloid Metaplasia Hematology 2025 Standard Therapy USA 68
    891 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 70
    892 Apheresis Allogeneic Acute Myelogenous Leukemia Hematology 2025 Standard Therapy Germany 62
    893 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 53
    894 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 52
    895 Apheresis Autologous Diffuse large B-cell lymphoma Hematology 2025 Standard Therapy Germany 63
    896 Apheresis Autologous Multiple myeloma Hematology 2025 Standard Therapy Germany 72
    897 Apheresis Autologous Central nervous system lymphoma Hematology 2025 Standard Therapy Germany 64
    898 Apheresis Allogeneic Acute myeloid leukemia Hematology 2025 Standard Therapy Germany 74
    899 Apheresis Allogeneic Myelodysplastic Syndrome Hematology 2025 Standard Therapy Germany 65
    900 Apheresis Allogeneic T-cell prolymphocytic leukemia Hematology 2025 Standard Therapy Germany 53